• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,022
93
67
64
53

COUNTRY

61
13
11
8
6

CATEGORIES

  • 83
  • 122
  • 65
  • 63
  • 37
  • 33
  • 10
  • 10
  • 12
  • 16

PRICE

558
815
1,664
2,771

PUBLISHED

4
163
519
2,771

PRODUCT TYPE

2,658
94
9
6
2
2

Oncology

(2,771 Products)

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Cell Press Reviews: Cancer Therapeutics. Cell Press Reviews Series

Cell Press Reviews: Cancer Therapeutics informs, inspires, and connects cancer researchers at all stages in their careers with timely, comprehensive reviews written by leaders in the field and curated...

December 2013

Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth

There are currently three monoclonal Antibody (mAb) treatments approved for metastatic colorectal cancer with the purpose of extending the patient’s lifespan; Avastin, Erbitux and Vectibix The current...

December 2013
FROM

Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth

Gastric and esophageal cancers are two orphan cancers of the gastrointestinal tract They are often diagnosed at advanced, incurable stages due to a late onset of symptoms, but are also associated with...

December 2013
FROM

Cancer Drug Design and Discovery. Edition No. 2

Cancer Drug Design and Discovery, Second Edition is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters...

December 2013

2014 World Tumor Markers Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country. The report also presents strategic analyses of leading...

December 2013
FROM

Physician Views: Bayer's M&A Catalyst – is Xofigo a Paradigm Shifter for the Prostate Cancer Market?

Already positioned as one of the most commercially promising new drug approvals of 2013, Algeta and Bayer's prostate cancer treatment Xofigo is now driving what appears to be the inevitable acquisition...

December 2013
FROM

Vaginal Cancer Global Clinical Trials Review, H2, 2013

Vaginal Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Vaginal Cancer clinical trial...

November 2013
FROM

Testicular Cancer Global Clinical Trials Review, H2, 2013

Testicular Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Testicular Cancer Global Clinical Trials Review, H2, 2013" provides data on the Testicular Cancer clinical...

November 2013
FROM

Metastatic Pancreatic Cancer Global Clinical Trials Review, H2, 2013

Metastatic Pancreatic Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Metastatic Pancreatic Cancer Global Clinical Trials Review, H2, 2013" provides data on the...

November 2013
FROM

Sezary Syndrome Global Clinical Trials Review, H2, 2013

Sezary Syndrome Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H2, 2013" provides data on the Sezary Syndrome clinical trial...

November 2013
FROM

Uterine Cancer Global Clinical Trials Review, H2, 2013

Uterine Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Uterine Cancer Global Clinical Trials Review, H2, 2013" provides data on the Uterine Cancer clinical trial...

November 2013
FROM

Esophageal Cancer Global Clinical Trials Review, H2, 2013

Esophageal Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Esophageal Cancer clinical...

November 2013
FROM

Gastric Cancer Global Clinical Trials Review, H2, 2013

Gastric Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Gastric Cancer Global Clinical Trials Review, H2, 2013" provides data on the Gastric Cancer clinical trial...

November 2013
FROM

EpiCast Report: Breast Cancer - Epidemiology Forecast to 2022

EpiCast Report: Breast Cancer - Epidemiology Forecast to 2022 Breast cancer is a malignant tumor that originates in the breast tissues According to the World Health Organization (WHO), breast cancer...

November 2013
FROM

Ovarian Cancer Global Clinical Trials Review, H2, 2013

Ovarian Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2013" provides data on the Ovarian Cancer clinical trial...

November 2013
FROM

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2022

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2022 Summary With more than 12 million new cases occurring worldwide each year, bladder cancer is estimated to be the ninth most common cancer,...

November 2013
FROM

Endometrial Cancer Global Clinical Trials Review, H2, 2013

Endometrial Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H2, 2013" provides data on the Endometrial Cancer clinical...

November 2013
FROM

Rhabdomyosarcoma Global Clinical Trials Review, H2, 2013

Rhabdomyosarcoma Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Rhabdomyosarcoma Global Clinical Trials Review, H2, 2013" provides data on the Rhabdomyosarcoma clinical...

November 2013
FROM

Oral Cancer Global Clinical Trials Review, H2, 2013

Oral Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Oral Cancer Global Clinical Trials Review, H2, 2013" provides data on the Oral Cancer clinical trial scenario....

November 2013
FROM

Throat Cancer Global Clinical Trials Review, H2, 2013

Throat Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Throat Cancer Global Clinical Trials Review, H2, 2013" provides data on the Throat Cancer clinical trial scenario....

November 2013
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)